glp-1-based therapies 💊 GLP-1 are reshaping obesity care. In a new Comment in The Lancet Global Health, World Obesity Federation experts and partners explore how these treatments could transform care for people living The Benefits of GLP-1 Therapy:

The table below summarizes the headline distinctions: Neither is inherently "better" for every person

We were thus prompted to explore the intriguing hypothesis that GSH-dependent control of ROS could play a role in defining the distinctive metabolic signaling of MZB and FoB

Mounjaro (tirzepatide) is a once-weekly subcutaneous injection prescribed to help adults with Type 2 diabetes manage blood sugar, alongside diet and exercise, similar to other GLP-1 medications like semaglutide

In the phase 3 trials, between 8 and 15% of participants didn't lose even 5% of their body weight, while others lost 30% or more

GLP-1s are becoming more common